MicroRNA Expression Profiling in HCV-Infected Human Hepatoma Cells Identifies Potential Anti-Viral Targets Induced by Interferon-α

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Zhang, Xiaozhen ^a   Daucher, Marybeth ^a   Armistead, David ^b   Russell, Rodney ^c   Kottilil, Shyam ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b Life Technologies Inc   (United States)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; MESSENGER RNA; MICRORNA; MICRORNA 130A; MICRORNA 192; MICRORNA 301; MICRORNA 30B; MICRORNA 30C; MICRORNA 324 5P; MICRORNA 565; UNCLASSIFIED DRUG;

ANTIVIRAL THERAPY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; GENE CONTROL; GENE EXPRESSION; GENERAL DEVICE; HEPATITIS C; HEPATOMA CELL; HOST CELL; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; TREATMENT OUTCOME; UPREGULATION; VIRUS ENTRY; VIRUS INFECTION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION PROFILING; HEPACIVIRUS; HUMANS; INTERFERON-ALPHA; LIVER; LIVER NEOPLASMS; UP-REGULATION; VIRUS REPLICATION;

EID: 84873896374     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055733     Document Type: Article

References (35)

1. Lindenbach BD, Rice CM, (2005) Unravelling hepatitis C virus replication from genome to function. Nature 436: 933-938.
2. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, et al. (1999) The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341: 556-562.
3. Poynard T, McHutchison J, Manns M, Trepo C, Lindsay K, et al. (2002) Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology. 122: 1303-1313.
4. Davis GL, Wong JB, McHutchison JG, Manns MP, Harvey J, et al. (2003) Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C. Hepatology. 38: 645-652.
5. Zeuzem S, Buti M, Ferenci P, Sperl J, Horsmans Y, et al. (2006) Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia. J Hepatol 44: 97-103.
6. Chen L, Sun J, Meng L, Heathcote J, Edwards AM, et al. (2010) ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment. J Gen Virol 91: 382-388.
7. Lempicki RA, Polis MA, Yang J, McLaughlin M, Koratich C, et al. (2006) Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: class prediction analyses before treatment predict the outcome of anti-HCV therapy among HIV-coinfected persons. J Infect Dis 193: 1172-1177.
8. Sidorkiewicz M, Grek M, Jozwiak B, Majda-Stanislawska E, Piekarska A, et al. (2010) Expression of microRNA-155 precursor in peripheral blood mononuclear cells from Hepatitis C patients after antiviral treatment. Acta Virol 54: 75-78.
9. Murakami Y, Tanaka M, Toyoda H, Hayashi K, Kuroda M, et al. (2010) Hepatic microRNA expression is associated with the response to interferon treatment of chronic hepatitis C. BMC Med Genomics. 3: 48.
10. Scagnolari C, Zingariello P, Vecchiet J, Selvaggi C, Racciatti D, et al. (2010) Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha. Virol J 7: 311.
11. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
12. Bushati N, Cohen SM, (2007) microRNA functions. Annu Rev Cell Dev Biol 23: 175-205.
13. Wang Y, Stricker HM, Gou D, Liu L, (2007) MicroRNA: past and present. Front Biosci 12: 2316-2329.
14. Bala S, Marcos M, Szabo G, (2009) Emerging role of microRNAs in liver diseases. World J Gastroenterol 15: 5633-5640.
15. Gottwein E, Cullen BR, (2008) Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe 3: 375-387.
16. John B, Enright AJ, Aravin A, Tuschl T, Sander C, et al. (2004) Human MicroRNA targets. PLoS Biol 2: e363.
17. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, et al. (2005) Combinatorial microRNA target predictions. Nat Genet 37: 495-500.
18. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
19. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
20. Roubelakis MG, Zotos P, Papachristoudis G, Michalopoulos I, Pappa KI, et al. (2009) Human microRNA target analysis and gene ontology clustering by GOmir, a novel stand-alone application. BMC Bioinformatics 10Suppl 6: S20.
21. Saito T, Saetrom P, (2010) MicroRNAs-targeting and target prediction. N Biotechnol 27: 243-249.
22. Sherman BT, Huang da W, Tan Q, Guo Y, Bour S, et al. (2007) DAVID Knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis. BMC Bioinformatics 8: 426.
23. Friedman RC, Farh KK, Burge CB, Bartel DP, (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105.
24. Garcia DM, Baek D, Shin C, Bell GW, Grimson A, et al. (2011) Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat Struct Mol Biol 18: 1139-1146.
25. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P, (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309: 1577-1581.
26. Sarasin-Filipowicz M, Krol J, Markiewicz I, Heim MH, Filipowicz W, (2009) Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat Med 15: 31-33.
27. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, et al. (2007) Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449: 919-922.
28. Hou X, Zhou R, Wei H, Sun R, Tian Z, (2009) NKG2D-retinoic acid early inducible-1 recognition between natural killer cells and Kupffer cells in a novel murine natural killer cell-dependent fulminant hepatitis. Hepatology 49: 940-949.
29. Yoshimura A, Suzuki M, Sakaguchi R, Hanada T, Yasukawa H, (2012) SOCS, Inflammation, and Autoimmunity. Front Immunol 3: 20.
30. Patsenker E, Stickel F, (2011) Role of integrins in fibrosing liver diseases. Am J Physiol Gastrointest Liver Physiol 301: G425-434.
31. Zhang ZX, Sonnerborg A, Sallberg M, (1994) A cell-binding Arg-Gly-Asp sequence is present in close proximity to the major linear antigenic region of HCV NS3. Biochem Biophys Res Commun 202: 1352-1356.
32. Chen Q, Seol DW, Carr B, Zarnegar R, (1997) Co-expression and regulation of Met and Ron proto-oncogenes in human hepatocellular carcinoma tissues and cell lines. Hepatology 26: 59-66.
33. Ueki T, Fujimoto J, Suzuki T, Yamamoto H, Okamoto E, (1997) Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma. Hepatology 25: 862-866.
34. Radaeva S, Jaruga B, Hong F, Kim WH, Fan S, et al. (2002) Interferon-alpha activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes. Gastroenterology 122: 1020-1034.
35. Bhanja Chowdhury J, Shrivastava S, Steele R, Di Bisceglie AM, Ray R, et al. (2012) Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A. J Virol 86: 10221-10225.